Narcotic Drugs Market

Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).
Narcotic Drugs Market aims to provide a comprehensive presentation of the global market for Narcotic (Opioid) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Narcotic (Opioid) Drugs. Narcotic Drugs Market contains market size and forecasts of Narcotic (Opioid) Drugs in global, including the following market information:
Global Narcotic (Opioid) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Narcotic (Opioid) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Codeine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Narcotic (Opioid) Drugs include Pfizer, Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, Johnson & Johnson, Merck and Mylan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Narcotic (Opioid) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Narcotic (Opioid) Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Narcotic (Opioid) Drugs Market Segment Percentages, by Type, 2022 (%)

• Codeine
• Fentanyl
• Hydrocodone
• Hydromorphone
• Meperidine
• Methadone
• Others

• Pain Relief Application
• Anesthesia Application

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Pfizer
• Teva
• Purdue Pharma
• Mallinckrodt
• Amneal Pharma
• Collegium
• Johnson & Johnson
• Merck
• Mylan
• Hikma Pharmaceuticals
• Sun Pharma
• Endo Pharmaceuticals
• Allergan